STAT3 and lung carcinoma: Considering the in vitro and in vivo inhibitory effect of STAT3i on nicotine-induced neutrophil activation and relatively low toxicity, BBB permeable STAT3 inhibitor could be used as a potential therapeutic agent to suppress onset of brain metastasis, particularly for lung cancer patients with a smoking history.